Sort
82,697 grants matching “vaccine development”
Microneedle-based immunization against pandemic influenza
$724,647Mark R Prausnitz · Georgia Institute Of Technology · R01 · FY2007 · EB
Tfh responses to novel vaccine candidates and protection from pediatric falciparum malaria
$724,615Jonathan D. Kurtis · Brown University · R01 · FY2017 · AI
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
$724,605Nora E Sarvetnick · University Of Nebraska Medical Center · R01 · FY2019 · AI
Ultrasensitive detection of Mycobacterium tuberculosis infection
$724,592Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R01 · FY2025 · AI
Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
$724,590Anne Moscona · Columbia University Health Sciences · R01 · FY2018 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$724,563David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Modification Of The Antigenicity & Virulence Of Rotaviruses By Reverse Genetics
$724,436John Patton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
IGF::OT::IGF: Pharmacokinetic and Pharmacodynamic Studies for Medications Development. PoP: 9/20/2017-9/19/2022. N01DA-17-8935.
$724,343Debra Kelsh · · N01 · FY2017 · DA
Intensifying Community Referrals for Health: The SINCERE Intervention to Address COVID-19 Health Disparities
$724,311Andrea Schneider Wallace · University Of Utah · R01 · FY2023 · NR
Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines
$724,299Jintanat Ananworanich · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2018 · AI
Infant immune mechanisms of HIV reservoir size and decay
$724,236Grace C John-Stewart · University Of Washington · R01 · FY2018 · HD
Mechanisms and Treatment of SARS-CoV-2 induced Lung Endothelial Injury
$724,225Jalees Rehman · University Of Illinois At Chicago · R01 · FY2024 · HL
Novel Prophylactic HIV Vaccines Based on rAAV Vectors
$724,215Childrens Hospital Of Philadelphia · P01 · FY2005 · AI
HCMV Vaccine produced from BAC-MVA that Blocks Epithelial and Fibroblast Entry
$724,200Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2016 · AI
Rational Design of Immunogens Targeting HIV-1 Quaternary Neutrlizing Epitopes
$724,096Xiangpeng Kong · New York University School Of Medicine · P01 · FY2012 · AI
Neisserial porins and antigen presenting cells
$724,093Lee Mark Wetzler · Boston Medical Center · R01 · FY2016 · AI
Improving predictive capacity of models for universal influenza vaccine development
$723,996Richard John Webby · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study
$723,924Benjamin W Van Voorhees · University Of Illinois At Chicago · R01 · FY2023 · MH
Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection
$723,878Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Therapy of Dengue with Modified Antibodies in Humanized Mice
$723,876Rebeca Rico-Hesse · Baylor College Of Medicine · R01 · FY2014 · AI
Vervet Research Colony as a Biomedical Resource
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2021 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2023 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2020 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2024 · OD
Component for Institution # 19-01414
$723,833Matthew Jorgensen · Wake Forest University Health Sciences · P40 · FY2021 · OD